Related Experiment Video

Updated: Jul 15, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Human metapneumovirus

Céline Deffrasnes1, Marie-Eve Hamelin, Guy Boivin

  • 1Department of Medical Biology, Faculty of Medicine, Laval University, Quebec, Canada.

Seminars in Respiratory and Critical Care Medicine
|April 27, 2007
PubMed

Insights

Human metapneumovirus (hMPV) causes respiratory infections in vulnerable groups. While no commercial treatments exist, research shows potential in ribavirin and experimental vaccines.

Area of Science:

  • Virology
  • Infectious Diseases
  • Pediatrics

Background:

  • Human metapneumovirus (hMPV), a paramyxovirus, causes significant upper and lower respiratory tract infections.
  • hMPV is a leading cause of pediatric hospitalizations for acute respiratory infections, often indistinguishable from RSV infections.
  • Infections occur in early childhood with common reinfections throughout life, particularly in the elderly and immunocompromised.

Purpose of the Study:

  • To review the clinical significance and current research landscape of hMPV.
  • To highlight diagnostic challenges and emerging therapeutic and preventative strategies.

Main Methods:

  • Literature review of hMPV epidemiology, clinical presentation, and diagnostic methods.
  • Summary of findings from experimental models evaluating therapeutic agents and vaccines.

Main Results:

  • hMPV infections mimic RSV, necessitating advanced diagnostics like RT-PCR.
  • Experimental models show promise for ribavirin and live attenuated vaccines against hMPV.
  • No commercial treatments are currently available for hMPV.

Conclusions:

  • hMPV is a significant respiratory pathogen requiring further research for effective treatments.
  • Development of targeted therapies and vaccines is crucial for managing hMPV infections.
  • Continued investigation into hMPV pathogenesis and control is warranted.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: